Home > Insider Trading > Filing (0001237899-14-000023)

Filing Details

Accession Number:: 0001237899-14-000023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-19 16:12:32
Reporting Period:: 2014-02-14

Filing Date:: 2014-02-19
Accepted Time:: 2014-02-19 16:12:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1487767	S Michael Aberman	777 Old Saw Mill River Road Tarrytown NY 10591	Vp Strategy And Investor Relat	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-14	7,500	$30.63	23,100	No	4	M	Direct
Common Stock	Disposition	2014-02-14	710	$323.30	22,390	No	4	F	Direct
Common Stock	Disposition	2014-02-14	3,142	$323.30	19,248	No	4	F	Direct
Common Stock	Disposition	2014-02-18	100	$324.81	19,148	No	4	S	Direct
Common Stock	Disposition	2014-02-18	200	$325.36	18,948	No	4	S	Direct
Common Stock	Disposition	2014-02-18	300	$327.56	18,648	No	4	S	Direct
Common Stock	Disposition	2014-02-18	100	$328.60	18,548	No	4	S	Direct
Common Stock	Disposition	2014-02-18	200	$329.34	18,348	No	4	S	Direct
Common Stock	Disposition	2014-02-18	200	$330.87	18,148	No	4	S	Direct
Common Stock	Disposition	2014-02-18	200	$331.16	17,948	No	4	S	Direct
Common Stock	Disposition	2014-02-18	1,100	$332.41	16,848	No	4	S	Direct
Common Stock	Disposition	2014-02-18	948	$333.50	15,900	No	4	S	Direct
Common Stock	Disposition	2014-02-18	300	$334.24	15,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-02-14	7,500	$0.00	7,500	$30.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000		2020-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	376	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $325.11 to $325.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on February 18, 2014 at prices ranging from $327.00 to $327.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $329.05 to $329.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $330.82 to $330.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $331.01 to $331.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 18, 2014 at prices ranging from $332.00 to $332.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 948 shares of Company stock on February 18, 2014 at prices ranging from $333.06 to $333.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on February 18, 2014 at prices ranging from $334.00 to $334.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.